Clinical Trial: Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Pilot Study of Immunoadsorption Therapy for Patients With Chronic Non-Ischemic Dilated Cardiomyopathy

Brief Summary: The purpose of this study is to evaluate the clinical safety and feasibility of Mysorba in patients with chronic non-ischemic dilated cardiomyopathy (DCM).

Detailed Summary:
Sponsor: Asahi Kasei Medical Co., Ltd.

Current Primary Outcome:

  • Rate of Procedure Related Serious Adverse Events (SAE) at 30 Days Post-treatment. [ Time Frame: 30 Days Post Treatment ]
  • Rate of Device Related Serious Adverse Events (SAE) at 30 Days Post-treatment. [ Time Frame: 30 days post-treatment ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Asahi Kasei Medical Co., Ltd.

Dates:
Date Received: November 7, 2011
Date Started: November 2011
Date Completion:
Last Updated: February 12, 2013
Last Verified: February 2013